Doug Schenkel Analyst PerformanceManaging Director at UBS GroupDoug Schenkel is a stock analyst at UBS Group in the healthcare sector, covering 23 publicly traded companies. Over the past year, Doug Schenkel has issued 30 stock ratings, including strong buy, buy, and hold recommendations. While full access to Doug Schenkel's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Doug Schenkel's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings49 Last 11 YearsBuy Recommendations71.74% 33 Buy RatingsCompanies Covered23 Unique Companies Ratings Distribution46RatingsDistribution of strong buy, buy, hold, and sell ratings by Doug Schenkel.RatingPercentageCount Strong Buy2.2%1 ratings Buy69.6%32 ratings Hold28.3%12 ratings Sell0.0%0 ratingsOut of 46 total stock ratings issued by Doug Schenkel at UBS Group, the majority (69.6%) have been Buy recommendations, followed by 28.3% Hold and 2.2% Strong Buy.Best & Worst CallsBest Call0000.0%GHSep 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%TBIOOct 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ47.8% of companies on NASDAQ11 companiesNYSE47.8% of companies on NYSE11 companiesOTCMKTS4.3% of companies on OTCMKTS1 companyDoug Schenkel, an analyst at UBS Group, currently covers 23 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare23 companies100.0%Doug Schenkel of UBS Group specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageLIFE SCIENCES TOOLS & SERVICES15 companies65.2%BIOTECHNOLOGY3 companies13.0%HEALTHCARE PROVIDERS & SERVICES2 companies8.7%HEALTHCARE EQUIPMENT & SUPPLIES2 companies8.7%HEALTHCARE TECHNOLOGY1 company4.3% Doug Schenkel's Ratings History at UBS Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsPACBPacific Biosciences of California11/9/2026Lower Price Target$2.36$2.70Neutral$0.0000.00% ROIVCYTVeracyte11/9/2026Lower Price Target$25.92$35.00Buy$0.0000.00% ROICAICaris Life Sciences11/5/2026Set Price Target$33.22$38.00$0.0000.00% ROISTVNStevanato Group11/4/2026Lower Price Target$13.29$16.00Neutral$0.0000.00% ROITMOThermo Fisher Scientific10/22/2026Reiterated Rating$686.44$800.00Buy$0.0000.00% ROIDHRDanaher10/22/2026Reiterated Rating$233.29$260.00Buy$0.0000.00% ROIGRALGRAIL10/2/2026Boost Price Target$138.32$175.00Buy$0.0000.00% ROIGRALGRAIL9/17/2026Set Price Target$75.11$84.00$0.0000.00% ROIHTFLHeartflow9/9/2026Initiated Coverage$47.75$55.00Neutral$0.0000.00% ROIGRALGRAIL9/9/2026Initiated Coverage$79.10$105.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. CAICaris Life Sciences9/9/2026Initiated Coverage$24.82$28.00Neutral$0.0000.00% ROIDHRDanaher9/9/2026Initiated Coverage$205.23$250.00Buy$0.0000.00% ROITEMTempus AI9/9/2026Initiated Coverage$64.29$70.00Neutral$0.0000.00% ROITWSTTwist Bioscience9/9/2026Initiated Coverage$128.06$144.00Neutral$0.0000.00% ROIILMNIllumina9/9/2026Upgrade$211.06$260.00Buy$0.0000.00% ROIWATWaters9/9/2026Upgrade$408.52$490.00Buy$0.0000.00% ROIWSTWest Pharmaceutical Services9/9/2026Boost Price Target$339.55$415.00Buy$0.0000.00% ROIRVTYRevvity9/9/2026Initiated Coverage$122.45$140.00Neutral$0.0000.00% ROIPACBPacific Biosciences of California9/9/2026Initiated Coverage$1.31$1.35Neutral$0.0000.00% ROINTRANatera9/9/2026Boost Price Target$325.80$435.00Buy$0.0000.00% ROIMTDMettler-Toledo International9/9/2026Initiated Coverage$1,299.83$1,460.00Neutral$0.0000.00% ROICAICaris Life Sciences9/9/2026Initiated Coverage$24.34$28.00Hold$0.0000.00% ROIDHRDanaher9/9/2026Upgrade$200.30Strong-Buy$0.0000.00% ROIGRALGRAIL9/9/2026Initiated Coverage$76.23$105.00Buy$0.0000.00% ROIHTFLHeartflow9/9/2026Initiated Coverage$49.88$55.00Hold$0.0000.00% ROIQGENQiagen9/9/2026Lower Price Target$42.39$47.00Hold$0.0000.00% ROIVCYTVeracyte9/9/2026Boost Price Target$40.87$65.00Buy$0.0000.00% ROITMOThermo Fisher Scientific9/8/2026Upgrade$603.43$730.00Buy$0.0000.00% ROIBRKRBruker12/10/2025Upgrade$45.36$60.00Outperform$0.0000.00% ROIWATWaters12/10/2025Upgrade$386.16$480.00Outperform$0.0000.00% ROIGHGuardant Health9/25/2025Upgrade$57.67$75.00Outperform$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche BankBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.